165 related articles for article (PubMed ID: 32149837)
1. SOX-10 and S100 Negative Desmoplastic Melanoma: Apropos a Diagnostically Challenging Case.
Kooper-Johnson S; Mahalingam M; Loo DS
Am J Dermatopathol; 2020 Sep; 42(9):697-699. PubMed ID: 32149837
[TBL] [Abstract][Full Text] [Related]
2. Desmoplastic melanoma with sarcomatoid dedifferentiation.
Kiuru M; McDermott G; Berger M; Halpern AC; Busam KJ
Am J Surg Pathol; 2014 Jun; 38(6):864-70. PubMed ID: 24618614
[TBL] [Abstract][Full Text] [Related]
3. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
[TBL] [Abstract][Full Text] [Related]
4. SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics.
Palla B; Su A; Binder S; Dry S
Am J Dermatopathol; 2013 Jul; 35(5):576-81. PubMed ID: 23291581
[TBL] [Abstract][Full Text] [Related]
5. Identification of nodal metastases in melanoma using sox-10.
Jennings C; Kim J
Am J Dermatopathol; 2011 Jul; 33(5):474-82. PubMed ID: 21552103
[TBL] [Abstract][Full Text] [Related]
6. An unusual case of desmoplastic melanoma containing an osteoclast-like giant cell-rich nodule.
Houang M; Castillo C; La Marca S; Combemale P; Wang Q; Paindavoine S; Pissaloux D; de la Fouchardiere A
Am J Dermatopathol; 2015 Apr; 37(4):299-304. PubMed ID: 24999544
[TBL] [Abstract][Full Text] [Related]
7. Primary intrafascial desmoplastic melanoma with pseudoglandular differentiation and aberrant cytokeratins expression: An exceptional presentation.
Saggini A; Cerroni L; Casini B; Baciorri F; Cota C
Pathol Res Pract; 2019 Dec; 215(12):152668. PubMed ID: 31585813
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review.
Bastos Junior Cde S; Piñeiro-Maceira JM; Moraes FM
An Bras Dermatol; 2013; 88(3):408-12. PubMed ID: 23793214
[TBL] [Abstract][Full Text] [Related]
10. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall.
Valero-Torres A; Prieto VG; Nagarajan P; Torres-Cabala CA; Tetzlaff MT; Curry JL; Ivan D; Aung PP
Am J Dermatopathol; 2017 Jun; 39(6):468-470. PubMed ID: 28525424
[TBL] [Abstract][Full Text] [Related]
11. Peripheral Palisading in Melanoma Mimicking Basal Cell Carcinoma: A Case Report.
Wang Y; Guo Y
Am J Dermatopathol; 2020 Sep; 42(9):677-679. PubMed ID: 32195676
[TBL] [Abstract][Full Text] [Related]
12. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
Zubovits J; Buzney E; Yu L; Duncan LM
Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI/C3 monoclonal antibody.
Fernando SS; Johnson S; Bäte J
Pathology; 1994 Jan; 26(1):16-9. PubMed ID: 8165017
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous desmoplastic melanoma.
Busam KJ
Adv Anat Pathol; 2005 Mar; 12(2):92-102. PubMed ID: 15731577
[TBL] [Abstract][Full Text] [Related]
15. S100, HMB-45, and Melan-A negative primary melanoma.
Shinohara MM; Deubner H; Argenyi ZB
Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
[TBL] [Abstract][Full Text] [Related]
16. A metastatic melanoma with an unusual immunophenotypic profile.
Gao Z; Stanek A; Chen S
Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
[TBL] [Abstract][Full Text] [Related]
17. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
18. Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases.
Romano RC; Carter JM; Folpe AL
Mod Pathol; 2015 Aug; 28(8):1033-42. PubMed ID: 26022451
[TBL] [Abstract][Full Text] [Related]
19. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
20. Undifferentiated Sarcoma as Intermediate Step in the Progression of Malignant Melanoma to Rhabdomyosarcoma: Histologic, Immunohistochemical, and Molecular Studies of a New Case of Malignant Melanoma With Rhabdomyosarcomatous Differentiation.
Tran TAN; Linos K; de Abreu FB; Carlson JA
Am J Dermatopathol; 2019 Mar; 41(3):221-229. PubMed ID: 30085960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
